DE69819703D1 - Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker - Google Patents

Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Info

Publication number
DE69819703D1
DE69819703D1 DE69819703T DE69819703T DE69819703D1 DE 69819703 D1 DE69819703 D1 DE 69819703D1 DE 69819703 T DE69819703 T DE 69819703T DE 69819703 T DE69819703 T DE 69819703T DE 69819703 D1 DE69819703 D1 DE 69819703D1
Authority
DE
Germany
Prior art keywords
isochinoline
substituted
ultra short
neuromuscular blocker
acting neuromuscular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69819703T
Other languages
English (en)
Other versions
DE69819703T2 (de
Inventor
Eric Cleveland Bigham
Grady Evan Boswell
John Joseph Savarese
Roy Archibald Swaringen Jr
Sanjay Shashikant Patel
Eric Eugene Boros
Robert Anthony Mook Jr
Vincente Samano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Avera Pharmaceuticals Inc
Original Assignee
Cornell Research Foundation Inc
Avera Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706117.0A external-priority patent/GB9706117D0/en
Priority claimed from GBGB9724987.4A external-priority patent/GB9724987D0/en
Application filed by Cornell Research Foundation Inc, Avera Pharmaceuticals Inc filed Critical Cornell Research Foundation Inc
Publication of DE69819703D1 publication Critical patent/DE69819703D1/de
Application granted granted Critical
Publication of DE69819703T2 publication Critical patent/DE69819703T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69819703T 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker Expired - Lifetime DE69819703T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9706117 1997-03-25
GBGB9706117.0A GB9706117D0 (en) 1997-03-25 1997-03-25 Ultra-short acting neuromuscular blockers
GBGB9724987.4A GB9724987D0 (en) 1997-11-27 1997-11-27 Ultra-short acting neuromuscular blockers
GB9724987 1997-11-27
PCT/EP1998/001651 WO1998042674A1 (en) 1997-03-25 1998-03-23 Substituted isoquinolines as ultra short acting neuromuscular blockers

Publications (2)

Publication Number Publication Date
DE69819703D1 true DE69819703D1 (de) 2003-12-18
DE69819703T2 DE69819703T2 (de) 2004-09-30

Family

ID=26311255

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69819703T Expired - Lifetime DE69819703T2 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
DE69830157T Expired - Lifetime DE69830157T2 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultrakurz wirkende neuromuskuläre blocker
DE69840816T Expired - Lifetime DE69840816D1 (de) 1997-03-25 1998-03-23 Isochinoline und deren Herstellung

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69830157T Expired - Lifetime DE69830157T2 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultrakurz wirkende neuromuskuläre blocker
DE69840816T Expired - Lifetime DE69840816D1 (de) 1997-03-25 1998-03-23 Isochinoline und deren Herstellung

Country Status (37)

Country Link
US (2) US6187789B1 (de)
EP (4) EP1526130A1 (de)
JP (3) JP4112015B2 (de)
KR (2) KR100578443B1 (de)
CN (1) CN1203061C (de)
AP (1) AP1797A (de)
AR (1) AR012156A1 (de)
AT (3) ATE295351T1 (de)
AU (2) AU745382B2 (de)
BR (1) BR9808422B1 (de)
CA (1) CA2284802C (de)
CO (1) CO4940499A1 (de)
CZ (1) CZ293786B6 (de)
DE (3) DE69819703T2 (de)
DK (2) DK0971898T3 (de)
EA (1) EA002224B1 (de)
EE (1) EE04113B1 (de)
ES (2) ES2242275T3 (de)
HK (1) HK1023342A1 (de)
HR (1) HRP980157B1 (de)
HU (1) HU228230B1 (de)
ID (1) ID22901A (de)
IL (1) IL131918A (de)
IS (2) IS2346B (de)
MA (1) MA26476A1 (de)
MY (1) MY121316A (de)
NO (1) NO314726B1 (de)
NZ (1) NZ337797A (de)
PE (1) PE68399A1 (de)
PL (1) PL190860B1 (de)
PT (2) PT971898E (de)
RS (1) RS49869B (de)
SI (1) SI0975599T1 (de)
TR (1) TR199902330T2 (de)
TW (1) TW505635B (de)
UY (1) UY24933A1 (de)
WO (2) WO1998042675A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199902330T2 (xx) * 1997-03-25 2000-02-21 Glaxo Group Limited Ultra k�sa etkili n�rom�sk�ler blokerler olarak ikameli izokuinolinler.
US6911455B2 (en) * 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
US6844904B2 (en) * 2002-12-07 2005-01-18 Cubic Corporation Fast PDLC device
EP1684753A2 (de) * 2003-10-28 2006-08-02 Cornell Research Foundation, Inc. Neuromuskuläre blockiermittel und ihre antagonisten
EP2101772B1 (de) * 2006-12-06 2012-04-25 Cornell Research Foundation, Inc. Neuromuskuläre blocker mit mittlerer dauer und antagonisten advon
EP2125742A2 (de) 2007-03-08 2009-12-02 Chemagis Ltd. Verfahren zur auftrennung von (1r,1'r)-atracuriumsalzen
EP2125743A1 (de) * 2007-03-26 2009-12-02 Chemagis Ltd. Verfahren zur auftrennung von (1r,1'r)-atracuriumsalzen
EP2155684B1 (de) 2007-05-01 2014-04-09 Chemagis Ltd. Verfahren zur herstellung von cisatracuriumverbindungen und damit assoziierte zwischenprodukte
AU2008273724B2 (en) 2007-05-01 2013-05-23 Chemagis Ltd. Process for Producing Cisatracurium and Associated Intermediates
CA2687157A1 (en) 2007-06-18 2008-12-24 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
US20100256381A1 (en) * 2007-07-09 2010-10-07 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
AU2008320380A1 (en) 2007-10-29 2009-05-07 Chemagis Ltd. Novel R,R'-atracurium salts
WO2009133556A2 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
WO2010107488A1 (en) * 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
CN102573794B (zh) 2009-08-19 2017-03-15 康奈尔大学 供生理注射用的半胱氨酸
WO2014005122A2 (en) * 2012-06-29 2014-01-03 Savarese John J Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
WO2014210369A2 (en) * 2013-06-28 2014-12-31 Cornell University Reversal of cysteine-inactivated neuromuscular blocking drugs with combinations of reversal agents
CN108375644B (zh) * 2016-12-07 2021-11-30 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN110776481B (zh) * 2018-07-24 2023-06-16 四川大学华西医院 一类双阳离子化合物及其制备方法和用途
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN111662230A (zh) * 2019-03-06 2020-09-15 四川道珍科技有限公司 一类苄基异喹啉化合物、制备方法和用途
CN110117297A (zh) * 2019-04-10 2019-08-13 珠海市赛纬电子材料股份有限公司 一种2-磷酸盐基硫酸丙烯酯的制备方法
WO2021115413A1 (zh) * 2019-12-11 2021-06-17 江苏恒瑞医药股份有限公司 神经肌肉阻滞剂及其制备方法
CN111471013B (zh) * 2020-05-26 2021-04-30 朗天药业(湖北)有限公司 一种米库氯铵及其注射液的制备方法
CN111909089B (zh) * 2020-08-14 2023-04-14 广东嘉博制药有限公司 一种米库氯铵对照品的制备方法
CN114057642B (zh) * 2021-12-10 2023-03-28 广东嘉博制药有限公司 一种米库氯铵中间体的合成方法
CN115073373A (zh) * 2022-07-08 2022-09-20 广东嘉博制药有限公司 一种不对称合成(r)-5’-甲氧基劳丹素的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
IL55254A (en) * 1977-08-01 1983-03-31 Massachusetts Gen Hospital Bis-isoquinolinium compounds,their preparation and pharmaceutical compositions containing them
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
BG41897A1 (en) * 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
GB9015473D0 (en) * 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
JPH04112016A (ja) * 1990-09-03 1992-04-14 Fuji Electric Co Ltd トランスファ成形金型用プランジャ及びトランスファ成形装置
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
TR199902330T2 (xx) * 1997-03-25 2000-02-21 Glaxo Group Limited Ultra k�sa etkili n�rom�sk�ler blokerler olarak ikameli izokuinolinler.

Also Published As

Publication number Publication date
AU6730598A (en) 1998-10-20
NZ337797A (en) 2001-03-30
ATE254107T1 (de) 2003-11-15
NO994680D0 (no) 1999-09-24
ATE295351T1 (de) 2005-05-15
SI0975599T1 (en) 2004-04-30
AP1797A (en) 2007-11-15
DK0975599T3 (da) 2004-03-15
MY121316A (en) 2006-01-28
IL131918A (en) 2005-09-25
WO1998042674A1 (en) 1998-10-01
EP1380573B1 (de) 2009-05-06
US6177445B1 (en) 2001-01-23
EE04113B1 (et) 2003-08-15
BR9808422A (pt) 2000-05-23
YU48399A (sh) 2002-06-19
US6187789B1 (en) 2001-02-13
JP4112015B2 (ja) 2008-07-02
KR100578443B1 (ko) 2006-05-11
AP9901658A0 (en) 1999-09-30
AU7521098A (en) 1998-10-20
NO994680L (no) 1999-11-24
CN1257483A (zh) 2000-06-21
IL131918A0 (en) 2001-03-19
EA199900756A1 (ru) 2000-08-28
HRP980157A2 (en) 1999-02-28
MA26476A1 (fr) 2004-12-20
BR9808422B1 (pt) 2010-08-24
JP2008019272A (ja) 2008-01-31
PL335885A1 (en) 2000-05-22
ID22901A (id) 1999-12-16
ES2242275T3 (es) 2005-11-01
UY24933A1 (es) 2000-12-29
CO4940499A1 (es) 2000-07-24
TR199902330T2 (xx) 2000-02-21
TW505635B (en) 2002-10-11
AR012156A1 (es) 2000-09-27
PL190860B1 (pl) 2006-02-28
IS5185A (is) 1999-09-17
CA2284802C (en) 2009-06-16
DE69840816D1 (de) 2009-06-18
HUP0001556A3 (en) 2002-01-28
ATE430734T1 (de) 2009-05-15
IS8717A (is) 2008-03-03
NO314726B1 (no) 2003-05-12
HRP980157B1 (en) 2004-10-31
CZ340499A3 (cs) 2000-04-12
EE9900424A (et) 2000-04-17
JP2002503220A (ja) 2002-01-29
KR100554601B1 (ko) 2006-03-03
EP1380573A3 (de) 2004-01-21
ES2210757T3 (es) 2004-07-01
EP0971898A1 (de) 2000-01-19
AU745382B2 (en) 2002-03-21
RS49869B (sr) 2008-08-07
DK0971898T3 (da) 2005-09-05
CA2284802A1 (en) 1998-10-01
WO1998042675A1 (en) 1998-10-01
IS2346B (is) 2008-03-15
HU228230B1 (en) 2013-02-28
EP1380573A2 (de) 2004-01-14
EP0975599A1 (de) 2000-02-02
DE69830157T2 (de) 2006-05-11
JP2002517168A (ja) 2002-06-11
EP0975599B1 (de) 2003-11-12
KR20010005621A (ko) 2001-01-15
KR20050103984A (ko) 2005-11-01
EP0971898B1 (de) 2005-05-11
EP1526130A1 (de) 2005-04-27
EA002224B1 (ru) 2002-02-28
JP4112016B2 (ja) 2008-07-02
DE69830157D1 (de) 2005-06-16
PT971898E (pt) 2005-07-29
PT975599E (pt) 2004-03-31
DE69819703T2 (de) 2004-09-30
CN1203061C (zh) 2005-05-25
HK1023342A1 (en) 2000-09-08
PE68399A1 (es) 1999-07-23
CZ293786B6 (cs) 2004-07-14
HUP0001556A2 (hu) 2001-04-28

Similar Documents

Publication Publication Date Title
DE69819703D1 (de) Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
DE69621226D1 (de) Polyolefin-polyamid konjugierter vliesstoff
ID23889A (id) Turunan-turunan piridina
DE59710982D1 (de) Cycloalkano-pyridine als CETP-Inhibitoren
EE9900059A (et) Puuteekraan
DE69634416D1 (de) Chinolin-derivate
DE69429069T2 (de) Falzpresse
ATE221052T1 (de) Tetrahydrochinolinderivate als eaa antagonisten
DE69822856D1 (de) Aminoterminal verkürztes rantes als chemokin antagonist
ATE221520T1 (de) Tetrahydrochinoline als nmda antagonisten
DE69819765D1 (de) Synchronkompensatoranlage
DE59701012D1 (de) Geldausgabeautomat
DE59606079D1 (de) Fahrbare Kehrmaschine
NO970128D0 (no) Skyvepanelkonstruksjon
DE59407285D1 (de) Imidazolochinoxalinonderivate als eaa antagonisten
IT1286448B1 (it) Spazzatrice mobile
DE29612085U1 (de) Fernwirkunterstation
KR970016153U (ko) 주방용 집게
ATE223380T1 (de) Heteroaryloxyethylaminen als 5-ht1a rezeptor liganden
DE29714769U1 (de) Schrankenständer
DE29516921U1 (de) Türsprechvorrichtung/Türsprechanlage
DE29710980U1 (de) Bewitterungsstabiler Vliesstoff
KR950027351U (ko) 반목 항타장치
DE29521745U1 (de) Fahrbare Kehrmaschine
KR980001328U (ko) 사무용 집게

Legal Events

Date Code Title Description
8364 No opposition during term of opposition